T
32
2
HCP
54
2
NTRS
35
10
FCX
44
4
CHD
34
7
GME
61
2
FAST
41
7
GM
55
6
UHS
50
4
EMN
40
5
TGT
35
4
NWS
69
5
BLK
46
2
VRSN
59
4
WAT
55
11
CHRW
53
2
SJM
17
5
CF
47
5
INTU
54
2
VTR
44
4
T
32
2
HCP
54
2
NTRS
35
10
FCX
44
4
CHD
34
7
GME
61
2
FAST
41
7
GM
55
6
UHS
50
4
EMN
40
5
TGT
35
4
NWS
69
5
BLK
46
2
VRSN
59
4
WAT
55
11
CHRW
53
2
SJM
17
5
CF
47
5
INTU
54
2
VTR
44
4
Financhill
Back

Rhythm Pharmaceuticals Vs. Nukkleus Industry Stock Comparison

Buy
57

RYTM
Rhythm Pharmaceuticals

Last Price:
$56.05
Seasonality Move:
-14.94%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Buy
57
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $56.12. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $56.12
    The current trend is relatively stagnant and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 46.95 Sell
Chaikin Money Flow: -727729 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.98 - 60.64) Sell
Bollinger Bands (100): (46.41 - 57.91) Buy

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.68 Buy
20-day SMA: 58.24 Sell
50-day SMA: 56.08 Buy
200-day SMA: 46.9 Buy
8-day EMA: 56.02 Buy
20-day EMA: 57.1 Sell
50-day EMA: 56 Buy
200-day EMA: 48.16 Buy

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.77 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):